All Outputs (4)

A real-world comparison of effectiveness and safety outcomes between clinical trial-eligible and -ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017)
Presentation / Conference
Mason, K., Barker, J., Smith, C., Hampton, P., Lunt, M., McElhone, K., …Burden, A. (2017, November). A real-world comparison of effectiveness and safety outcomes between clinical trial-eligible and -ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR). Paper presented at Psoriasis Gene to Clinic, 8th International Congress, The Queen Elizabeth II Conference Centre, London, UK

Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017)
Presentation / Conference
Mason, K. J., Lunt, M., Hunter, H. J., Jabbar-Lopez, Z. K., Kirby, B., Kleyn, C. E., …Grp, B. A. D. B. I. R. S. (2017, November). Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Paper presented at Psoriasis Gene to Clinic, 8th International Congress, The Queen Elizabeth II Conference Centre, London, UK

Completeness of reporting of overnight hospitalisations to a psoriasis pharmacovigilance register and the National Health Service Wales Informatics Service (2017)
Presentation / Conference
Mason, K. J., Ali, H., Reynolds, N. J., Burden, A. D., Smith, C. H., Evans, I., …Griffiths, C. E. . M. (2017, August). Completeness of reporting of overnight hospitalisations to a psoriasis pharmacovigilance register and the National Health Service Wales Informatics Service. Paper presented at 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Palais de Congres de Montreal, Montreal, Canada

Background: The British Association of Dermatologists Biologic Interventions Register (BADBIR) is a longitudinal, observational, web-based pharmacovigilance register of patients with moderate-to-severe psoriasis. Patients are currently recruited from... Read More about Completeness of reporting of overnight hospitalisations to a psoriasis pharmacovigilance register and the National Health Service Wales Informatics Service.

Persistence with second-line biological therapies in patients with psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017)
Presentation / Conference
Iskandar, I. Y. K., Warren, R., Lunt, M., Mason, K. J., Evans, I., McElhone, K., …Ashcroft, D. M. (2017, July). Persistence with second-line biological therapies in patients with psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Paper presented at The 97th Annual meeting of the British Association of Dermatologists, The Arena and Convention Centre Liverpool, Liverpool, United Kingdom